efficacy of Herbal drug Hinguvachadi choorna in comparison with Metformin in the management of PCOS.

Study of effectiveness of Hinguvachadi choorna in comparison with Metformin for reducing ovarian volume & follicle count in PCOS. (Randomized control clinical trial). - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081719

Enrollment

Registered

2025-03-05

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N738- Other specified female pelvic inflammatory diseases

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1The age group between18 to 45 years 2The subjects with PCOS having follicle count more than 20 per ovary in either overy and an ovarian volume of more than 10 cm3 on either ovary 3Subject irrespective of marital status obstetric status education and occupation

Exclusion criteria

Exclusion criteria: 1.Pregnant or breastfeeding females. 2.Conditions that mimick PCOS like Cushing s disease, acromegaly, ovarian insufficiency, hyperprolactinemia, thyroid dysfunction or non-classical congenital adrenal hyperplasia. 3.Females who have received hormonal therapy in the last 3 months. 4. Diagnosed with Diabetes mellitus

Design outcomes

Primary

Measure	Time frame
PRIMARY OUTCOME: - Reduction in Ovarian volume and follicle count in the females with PCOS. SECONDARY OUTCOME: Reduction in weight, abdominal girth and hirusitism. Regular menstrual cycles. Timepoint: 0day, 30day, 60day	—

Secondary

Measure	Time frame
SECONDARY OUTCOME Reduction in weight abdominal girth & hirusitism Regular menstrual cycles Timepoint: 90 day	—

Countries

India

Contacts

Public ContactDr Swati Surendra Mohite

Bharati Vidyapeeth University, Pune

swati.mohite@bharatividyapeeth.edu9822004562

Outcome results